20th Anniversary Highlights of Hope
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(PRINCIPAL INVESTIGATORS, LEFT TO RIGHT) DRS. SCOTT ROTHBART,<br />
PETER JONES, HUI SHEN, PETER LAIRD, GERD PFEIFER, PIROSKA SZABÓ,<br />
STEFAN JOVINGE AND STEVEN J. TRIEZENBERG.<br />
a growing field that presents an excellent<br />
opportunity for treating some <strong>of</strong> the biggest<br />
threats to human health.<br />
Jones knew epigenetics was one area where<br />
the Institute could truly become the best <strong>of</strong><br />
the best. When he arrived in Grand Rapids,<br />
he set the Institute on an ambitious new<br />
course—to become a world-renowned<br />
hub for epigenetics research and in doing<br />
so, to find new ways to better treat cancer,<br />
Parkinson’s and other diseases.<br />
“Patients don’t have the time to wait and<br />
neither do we,” Jones said. “We have the<br />
opportunity to make a real difference in<br />
people’s lives.”<br />
There hasn’t been much waiting since<br />
Jones arrived in 2014. The number <strong>of</strong><br />
faculty has grown dramatically from 23<br />
to 33 investigators, many with a focus on<br />
epigenetics. Reflecting the rise <strong>of</strong> Big Data,<br />
VARI has massively upgraded its computing<br />
power and technological capabilities to<br />
support large-scale genomic, epigenomic<br />
and structural studies aimed at unraveling<br />
the molecular underpinnings <strong>of</strong> health and<br />
“Patients don't have the time to<br />
wait and neither do we. We have the<br />
opportunity to make a real difference<br />
in people's lives.”<br />
- Dr. Peter Jones<br />
CONTINUED ON PG 26 ><br />
VAN ANDEL INSTITUTE HIGHLIGHTS OF HOPE | 25